Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000325 · ClinicalTrials.gov registry record · Phase 1
Psychostimulant Abuse - Novel Treatment Approaches - 1
A Phase 1 study, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
- Phase 1
- Development phase
NCT00000325: Completed Phase 1 study, sponsored by National Institute on Drug Abuse (NIDA).
NCT00000325 is a Phase 1 study that has completed, run by National Institute on Drug Abuse (NIDA). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000325, a Phase 1 study, has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
To determine if acute assessments of profasi and factrel affect plasma cocaine levels and cocaine-induced behavioral changes in men.
Interventions
- BEHAVIORAL Gonadorelin
Trial Details
| Field | Value |
|---|---|
| Est. Completion | 2001-12 |
| Phase | Phase 1 |
What the finished NCT00000325 record still lists
NCT00000325 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Gonadorelin is the first listed.
NCT00000325 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000325 about?
NCT00000325 is a clinical study titled "Psychostimulant Abuse - Novel Treatment Approaches - 1". To determine if acute assessments of profasi and factrel affect plasma cocaine levels and cocaine-induced behavioral changes in men.
What is the current status of trial NCT00000325?
This trial is currently completed. It is a Phase 1 study. Estimated completion is 2001-12.
What interventions are being tested in trial NCT00000325?
The interventions under investigation include: Gonadorelin (BEHAVIORAL).
Who is sponsoring clinical trial NCT00000325?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.